<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>White birch sublingual tablet (United States: Not available): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">White birch sublingual tablet (United States: Not available): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">White birch sublingual tablet (United States: Not available): Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="129917" href="/d/html/129917.html" rel="external">see "White birch sublingual tablet (United States: Not available): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list canbnlist drugH1Div drugBrandNames" id="F54997498"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Itulatek</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F54997500"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Allergen-Specific Immunotherapy</li></ul></div>
<div class="block doa drugH1Div" id="F54997516"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="520a12b6-9fb3-4571-b10f-7071da933972">Tree pollen–induced allergic rhinitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tree pollen (alder, birch, and/or hazel)–induced allergic rhinitis:</b>
<b>Sublingual:</b> Adults ≤65 years of age: 1 tablet once daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F54997517"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F54997518"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F54975494"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Reported adverse reactions are for adolescents and adults.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Pruritus of ear (13%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Oral paresthesia (11%), tongue pruritus (13%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local pruritus (oral: 39%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Throat irritation (29%; including chronic throat clearing and larynx irritation)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Chest discomfort (1%), lip edema (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Urticaria (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Dysgeusia (1%), dyspepsia (1%), dysphagia (3%), glossalgia (3%), lip pruritus (4%), oral discomfort (6%), oral hypoesthesia (5%), stomatitis (2%), swelling of lips (7%), swelling of mouth (9%), swollen tongue (6%)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Mouth edema (3%)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Foreign body sensation (2%), voice disorder (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Allergic conjunctivitis (1%), increased lacrimation (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Cough (6%), dry throat (2%), dyspnea (1%), oropharyngeal pain (6%), pharyngeal disease (paresthesia: 1%; hypoesthesia), pharyngeal edema (8%; including oropharyngeal edema), rhinitis (1%), rhinorrhea (2%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: ECG abnormality, flushing, tachycardia</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Atopic dermatitis, eczema, erythema of skin, skin rash, xeroderma</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Abnormal aspartate transaminase, abnormal lactate dehydrogenase, abnormal transaminase</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Acid regurgitation, change in appetite, diarrhea, esophageal pain, flatulence, gastric hyperacidity (gastric pH decreased), gastric irritation (esophageal irritation), gastritis, gastroesophageal reflux disease, gastrointestinal distress (esophageal discomfort), gastrointestinal pain, gingival erythema, gingival swelling, glossitis, lip blister, oral herpes simplex infection, oral inflammation (enlarged uvula), oral mucosa ulcer, oropharyngeal blister, palatal edema, tongue ulcer (including blister), upper abdominal pain, vomiting, xerostomia</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Mucocutaneous hemorrhage</p>
<p style="text-indent:-2em;margin-left:4em;">Hepatic: Abnormal bilirubin levels</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Angioedema, seasonal allergy (exacerbation), tongue edema</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local swelling (can be severe or may increase in severity over time)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Burning sensation, choking sensation, dysarthria, fatigue, feeling hot, malaise, restlessness, speech disturbance</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Joint swelling, limb pain, musculoskeletal pain, myalgia</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Conjunctival hyperemia, conjunctivitis, eye irritation, eyelid edema, foreign body sensation of eye</p>
<p style="text-indent:-2em;margin-left:4em;">Otic: Ear sign or symptom (discomfort), tinnitus</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Asthma, epistaxis, increased bronchial secretions (catarrh), laryngeal edema, nasal discomfort, oropharyngeal irritation (discomfort), paranasal sinus hypersecretion (upper airway), pharyngeal erythema, sinusitis</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Swelling, wound</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Hypersensitivity: Hypersensitivity reaction (may be severe hypersensitivity reaction)</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Gastrointestinal: Eosinophilic esophagitis, nausea</p></div>
<div class="block coi drugH1Div" id="F54997508"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to white birch allergen extract or any component of the formulation; previous severe systemic allergic reaction to birch or related tree pollen immunotherapy; unstable, severe, or uncontrolled chronic or seasonal asthma (FEV<sub>1</sub> &lt;70% of predicted value after adequate pharmacologic treatment); concurrent use with beta blockers; active inflammatory conditions in the oral cavity (eg, oral lichen planus with ulcerations, severe oral candidiasis, dental extraction); history of eosinophilic esophagitis.</p>
<p style="text-indent:-2em;margin-left:2em;">Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block war drugH1Div" id="F54997509"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Allergic reactions: <b>[Canadian Boxed Warning]: Systemic allergic reactions, including severe local allergic reactions, may occur. </b>Some reactions may be life threatening. Depending on the reaction severity, temporarily or permanently discontinue treatment in any patient that develops clinical evidence of a severe systemic or severe local allergic reaction. <b>Emergency administration of epinephrine, antihistamines, bronchodilators, or systemic corticosteroids may be necessary.</b></p>
<p style="text-indent:-2em;margin-left:4em;">• Esophagitis: Eosinophilic esophagitis has been reported with sublingual tablet immunotherapy; discontinue therapy in patients who experience severe or persistent gastroesophageal symptoms (eg, dysphagia, chest pain).</p>
<p style="text-indent:-2em;margin-left:4em;">• Localized effects: Local administration site reactions (eg, itching, irritation, sensation changes, discomfort, swelling, pain) of the mouth, throat, and ears may occur.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Disease-related concerns:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Cardiovascular disease: Use with caution in patients with severe cardiovascular disease, unstable angina, recent myocardial infarction, or uncontrolled hypertension; may be at increased risk of severe hypersensitivity.</p>
<p style="text-indent:-2em;margin-left:4em;">• Respiratory disease: In patients with controlled asthma and who are experiencing an acute respiratory infection, delay treatment initiation until the infection has resolved.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Immunocompromised patients: Use with caution in patients with active systemic autoimmune disorders, immune defects, immunodeficiencies, immunosuppression, or malignancy.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Initiate therapy at least 16 weeks prior to the tree pollen season and maintain treatment throughout the season. The first dose of therapy should be administered in a health care setting under the supervision of a physician. Use with caution in patients previously administered epinephrine to treat severe allergic reactions; use of allergen immunotherapy has not been studied in these patients. Additionally, the effect of epinephrine may be potentiated or inhibited by tricyclic antidepressants, monoamine oxidase inhibitors, catechol-O-methyltransferase inhibitors, and/or beta blockers, which may be life threatening. Instruct patients on appropriate use of epinephrine and to obtain immediate medical care upon its use.</p>
<p style="text-indent:-2em;margin-left:4em;">• Experienced physician: <b>[Canadian Boxed Warning]: Should only be prescribed and initiated by physicians adequately trained and experienced in the treatment of respiratory allergic diseases. </b></p>
<p style="text-indent:-2em;margin-left:4em;">• Food allergy: Tree pollen allergic patients may experience oral allergy symptoms (eg, oropharyngeal pruritus, swelling) from consumption of tree pollen cross-reacting foods. Patients with tree pollen-related food allergy may more often experience local reactions and temporary treatment interruptions compared to patients without tree pollen-related food allergy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Monitoring: <b>[Canadian Boxed Warning]: Monitor all patients for at least 30 minutes after initial dose in a health care setting.</b></p>
<p style="text-indent:-2em;margin-left:4em;">• Oral inflammation/wounds: Temporarily interrupt therapy to allow for complete healing of the oral cavity due to oral inflammation (eg, oral lichen planus, mouth ulcers, thrush) or oral wounds following oral surgery, tooth loss, or dental extraction.</p></div>
<div class="block prod-avail drugH1Div" id="F54997505"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Not available in the United States.</p></div>
<div class="block geq drugH1Div" id="F55049292"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block dinfoc drugH1Div" id="F55049294"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Sublingual, Sublingual: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Itulatek: 12 SQ-BET [contains gelatin (fish)]</p></div>
<div class="block adm drugH1Div" id="F54997519"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Oral:</b> Administer the first dose in a health care setting due to the potential for allergic reactions; monitor patient for ≥30 minutes after first dose. If well tolerated, subsequent doses may be taken at home. With dry hands, remove sublingual tablet from blister immediately prior to administration. Place tablet under tongue until completely dissolved and then wait at least 1 minute before swallowing. Wash hands after handling tablet. Avoid food or beverage for 5 minutes following administration.</p></div>
<div class="block use drugH1Div" id="F54997503"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Tree pollen (alder, birch, and/or hazel)–induced allergic rhinitis:</b> Treatment of moderate to severe seasonal allergic rhinitis, with or without conjunctivitis, induced by pollen from birch, alder, and/or hazel, in adults 18 to 65 years of age who have a clinical history of symptoms of allergic rhinitis, despite use of symptom-relieving medication, and a positive test of sensitization to ≥1 of the pollen of birch, alder, or hazel (skin prick test and/or specific IgE).</p></div>
<div class="block mst drugH1Div" id="F54997497"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:0em;margin-left:2em;">
<b>ALERT: Canadian Boxed Warning:</b> Health Canada–approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling.</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F54992699"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F54992696"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Beta-Blockers: May enhance the adverse/toxic effect of White Birch Allergen Extract. Specifically, beta-blockers may reduce the effectiveness of beta-agonists that may be required to treat systemic reactions to white birch allergen extract.<i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F55003688"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">In general, allergen immunotherapy should not be initiated during pregnancy (Dykewicz 2020; Pitsios 2019).</p></div>
<div class="block brc drugH1Div" id="F54997507"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">It is not known if white birch allergen extract is present in breast milk.</p></div>
<div class="block mop drugH1Div" id="F54997521"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Signs/symptoms of hypersensitivity; monitor patients for at least 30 minutes after administration of first dose.</p></div>
<div class="block pha drugH1Div" id="F54997512"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">The effects of allergy immunotherapy may include changes in allergen specific antibodies and regulatory T-cells leading to long-term tolerance.</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-32707227">
<a name="32707227"></a>Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. <i>J Allergy Clin Immunol</i>. 2020;146(4):721-767. doi:10.1016/j.jaci.2020.07.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/white-birch-sublingual-tablet-united-states-not-available-drug-information/abstract-text/32707227/pubmed" id="32707227" target="_blank">32707227</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Itulatek (white birch allergen extract) [product monograph]. Hørsholm Denmark: ALK-Abelló A/S; January 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31528333">
<a name="31528333"></a>Pitsios C, Tsoumani M, Bilò MB, et al. Contraindications to immunotherapy: a global approach. <i>Clin Transl Allergy</i>. 2019;9:45. doi:10.1186/s13601-019-0285-4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/white-birch-sublingual-tablet-united-states-not-available-drug-information/abstract-text/31528333/pubmed" id="31528333" target="_blank">31528333</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 130043 Version 17.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
